BioCentury | Oct 12, 2015
Politics, Policy & Law

Trans-Pacific politics

The biopharma industry is again at the center of a massive political dispute, this time over the Trans-Pacific Partnership. After fighting and losing a battle to persuade or force the rest of the world to...
BioCentury | Mar 12, 2015
Translation in Brief

Changing CHO Cells

CHO cells are a key tool used throughout the industry, from cell-based studies in basic research to commercial-scale production of biologics, but until the cell line's full genome was published in 2013, manipulation of the...
BioCentury | Aug 1, 2013
Politics & Policy

U.K. announces L93.2M package for life sciences

The U.K. government announced L93.2 million ($143.5 million) in funding to support life sciences. The funding includes L25.9 million in awards from the third round of the Biomedical Catalyst fund; a L38 million National Biologics...
BioCentury | Mar 10, 1997
Company News

Serologicals deal

...SERO acquired Nations Biologics Inc. and its Nations Group affiliates for about $14.5 million in cash and notes...
BioCentury | Mar 1, 1993
Company News

Epitope sales and marketing update

Epitope Inc. (EPT) Epitope Inc. (EPT) announced three marketing/manufacturing deals related to its Orasure oral specimen collection device. EPT and China National Biological Products Corp. (China National), a marketing arm of the Chinese government, have...
Items per page:
1 - 5 of 5
BioCentury | Oct 12, 2015
Politics, Policy & Law

Trans-Pacific politics

The biopharma industry is again at the center of a massive political dispute, this time over the Trans-Pacific Partnership. After fighting and losing a battle to persuade or force the rest of the world to...
BioCentury | Mar 12, 2015
Translation in Brief

Changing CHO Cells

CHO cells are a key tool used throughout the industry, from cell-based studies in basic research to commercial-scale production of biologics, but until the cell line's full genome was published in 2013, manipulation of the...
BioCentury | Aug 1, 2013
Politics & Policy

U.K. announces L93.2M package for life sciences

The U.K. government announced L93.2 million ($143.5 million) in funding to support life sciences. The funding includes L25.9 million in awards from the third round of the Biomedical Catalyst fund; a L38 million National Biologics...
BioCentury | Mar 10, 1997
Company News

Serologicals deal

...SERO acquired Nations Biologics Inc. and its Nations Group affiliates for about $14.5 million in cash and notes...
BioCentury | Mar 1, 1993
Company News

Epitope sales and marketing update

Epitope Inc. (EPT) Epitope Inc. (EPT) announced three marketing/manufacturing deals related to its Orasure oral specimen collection device. EPT and China National Biological Products Corp. (China National), a marketing arm of the Chinese government, have...
Items per page:
1 - 5 of 5